1176364

Pfizer Inc. — FEI 2416101

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Sponsor, Contract Research Organization